Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.
Courtney M RowanBrenna LaBereCameron C YoungLaura D ZambranoMargaret M NewhamsSuden KucukakElizabeth R McNamaraElizabeth H MackJulie C FitzgeraldKatherine IrbyAline B MadduxJennifer E SchusterMichele KongHeda DapulStephanie P SchwartzMelania M BembeaLaura L LoftisAmanda R KolmarChristopher J BabbittRyan A NofzigerMark W HallShira J GertzNatalie Z CvijanovichMatt S ZinterNatasha B HalasaTamara T BradfordGwenn E McLaughlinAalok R SinghCharlotte V HobbsKari WellnitzMary A StaatBria M CoatesHillary R CrandallMia MaamariKevin M HavlinAdam J SchwarzChristopher L CarrollEmily R LevyKristin L MoffittAngela P CampbellAdrienne G RandolphJanet Chounull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
In this national case series of patients <21 years of age with acute COVID-19 admitted for intensive care, existence of a prior ICCs were associated with worse clinical outcomes. Reassuringly, most patients with ICCs hospitalized in the PICU for severe acute COVID-19 survived and were discharged home without new severe morbidities.
Keyphrases
- coronavirus disease
- sars cov
- liver failure
- end stage renal disease
- respiratory failure
- drug induced
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- respiratory syndrome coronavirus
- peritoneal dialysis
- prognostic factors
- type diabetes
- early onset
- intensive care unit
- hepatitis b virus
- skeletal muscle
- young adults
- insulin resistance